Similarly, methylenetetrahydrofolate reductase (MTHFR), a rate-limiting enzyme in the methyl cycle, may be implicated as high levels of homocysteine, observed in AD patients, are associated with vascular damage, increased inflammation, and endothelial dysfunction [106]. The gene discussed is MTHFR; the disease is endothelial dysfunction.